PHARMALA BIOTECH HOLDINGS INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of MDMA for the last quarter is 52.56 k CAD, and it's 62.41% lower compared to the previous quarter. The net income of Q4 24 is -224.35 k CAD.